Page last updated: 2024-08-24

n-acetylaspartic acid and Ophthalmoplegia, Progressive Supranuclear

n-acetylaspartic acid has been researched along with Ophthalmoplegia, Progressive Supranuclear in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's0 (0.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barker, GJ; Blain, CR; Guevara, CA; Leigh, PN; Lythgoe, DJ; Stahl, D1
Bienaimée, MJ; Delmaire, C; Galanaud, D; Gaymard, B; Hartmann, A; Jodoin, N; Lannuzel, A; Lehéricy, S; Roze, E; Vidailhet, M1
De Mari, M; Federico, F; Giannini, P; Iliceto, G; Lamberti, P; Lucivero, V; Mezzapesa, DM; Simone, IL1
Bertolino, A; Bonavita, S; Hallett, M; Litvan, I; Lundbom, N; Patronas, NJ; Tedeschi, G1
Barker, GJ; Davie, CA; Lees, AJ; Machado, C; Miller, DH1
de Mari, M; Federico, F; Ferrari, E; Lamberti, P; Lucivero, V; Mezzapesa, DM; Petruzzellis, M; Simone, IL1

Trials

1 trial(s) available for n-acetylaspartic acid and Ophthalmoplegia, Progressive Supranuclear

ArticleYear
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.
    Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:3

    Topics: Aged; Aspartic Acid; Corpus Striatum; Creatine; Globus Pallidus; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Parkinson Disease; Phosphocreatine; Putamen; Statistics, Nonparametric; Supranuclear Palsy, Progressive

1997

Other Studies

5 other study(ies) available for n-acetylaspartic acid and Ophthalmoplegia, Progressive Supranuclear

ArticleYear
Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
    European journal of neurology, 2010, Volume: 17, Issue:9

    Topics: Aged; Aspartic Acid; Basal Ganglia Diseases; Biomarkers; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Neurons; Parkinson Disease; Predictive Value of Tests; Supranuclear Palsy, Progressive

2010
Magnetic resonance imaging lesion pattern in Guadeloupean parkinsonism is distinct from progressive supranuclear palsy.
    Brain : a journal of neurology, 2010, Volume: 133, Issue:Pt 8

    Topics: Aged; Aspartic Acid; Brain; Case-Control Studies; Cognition Disorders; Creatinine; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; Female; Guadeloupe; Hallucinations; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Parkinsonian Disorders; Supranuclear Palsy, Progressive

2010
Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration.
    Brain : a journal of neurology, 1997, Volume: 120 ( Pt 9)

    Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Diseases; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Phosphocreatine; Protons; Supranuclear Palsy, Progressive; Tissue Distribution

1997
Proton magnetic resonance spectroscopy in Steele-Richardson-Olszewski syndrome.
    Movement disorders : official journal of the Movement Disorder Society, 1997, Volume: 12, Issue:5

    Topics: Adult; Aged; Aspartic Acid; Basal Ganglia; Case-Control Studies; Choline; Creatine; Diagnosis, Differential; Globus Pallidus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Middle Aged; Supranuclear Palsy, Progressive

1997
Usefulness of proton magnetic resonance spectroscopy in differentiating parkinsonian syndromes.
    Italian journal of neurological sciences, 1999, Volume: 20, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Brain; Choline; Creatine; Diagnosis, Differential; Disease Progression; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Parkinsonian Disorders; Phosphocreatine; Supranuclear Palsy, Progressive

1999